Search Results - "Garratt, C. J."

Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial by Fitchet, A, Doherty, P J, Bundy, C, Bell, W, Fitzpatrick, A P, Garratt, C J

“…Objective: To investigate the effects of a 12 week comprehensive cardiac rehabilitation (CCR) programme on patients who have undergone implantation of an…”
Get full text

QT dispersion and mortality after myocardial infarction by Glancy, J M, Garratt, C J, Woods, K L, de Bono, D P

“…QT dispersion may serve as a measure of variability in ventricular recovery time and may be a means of identifying patients at risk of arrhythmias and sudden…”
Get more information

Reproducibility and automatic measurement of QT dispersion by Glancy, J. M., Weston, P. J., Bhullar, H. K., Garratt, C. J., Woods, K. L., de Bono, D. P.

“…This study investigated interobserver (two observers) and intrasubject (two measurements) reproducibility of QT dispersion from abnormal electrocardiograms in…”
Get full text

Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans by HOBBS, W. J. C, FYNN, S, TODD, D. M, WOLFSON, P, GALLOWAY, M, GARRATT, C. J

“…Although atrial electrical remodeling has been studied extensively in animal models, the reversibility of this phenomenon after termination of clinical atrial…”
Get full text

Signal averaged P wave compared with standard electrocardiography or echocardiography for prediction of atrial fibrillation after coronary bypass grafting by Stafford, P. J., Kolvekar, S., Cooper, J., Fothergill, J., Schlindwein, F., deBono, D. P., Spyt, T. J., Garratt, C. J.

“…OBJECTIVE: To define the clinical value of the signal averaged P wave (SAPW) and to compare it with the standard electrocardiogram (ECG), echocardiogram, and…”
Get full text

Sibutramine pharmacokinetics in young and elderly healthy subjects by HIND, I. D, MANGHAM, J. E, GHANI, S. P, HADDOCK, R. E, GARRATT, C. J, JONES, R. W

“…To investigate the pharmacokinetics of the pharmacologically active metabolites of sibutramine (metabolites 1 and 2) in healthy young and elderly volunteers…”
Get full text

Ventricular tachycardia as default diagnosis in broad complex tachycardia by Griffith, M J, Garratt, C J, Mounsey, P, Camm, A J

“…In the differential diagnosis of broad-complex tachycardia, the most important decision is whether or not the tachycardia is ventricular, since this type…”
Get more information

On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1 by Stephens, G J, Garratt, J C, Robertson, B, Owen, D G

“…1. This study used the whole-cell patch clamp technique to investigate the mechanism of action of the K+ channel blocker 4-aminopyridine (4-AP) on the cloned…”
Get full text

Reproducibility of the signal averaged P wave: time and frequency domain analysis by Stafford, P. J., Cooper, J., Fothergill, J., Schlindwein, F., deBono, D. P., Garratt, C. J.

“…OBJECTIVE: To assess the reproducibility of time and frequency domain variables derived from the signal averaged P wave. DESIGN: Longitudinal within patient…”
Get full text

The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation by Fynn, S. P., Garratt, C. J.

Get full text

The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death by Lau, E W, Griffith, M J, Pathmanathan, R K, Ng, G A, Clune, M M, Cooper, J, Marshall, H J, Forsey, P R, Stafford, P J, Gray, R G, Skehan, J D, Garratt, C J

“…MAVERIC was a randomised clinical trial designed to test the possibility of prospectively identifying patients who would benefit most from the implantable…”
Get full text

A new evidence base for implantable defibrillator therapy by Garratt, C J

Get full text

Radiofrequency catheter ablation of Mahaim tachycardia by targeting Mahaim potentials at the tricuspid annulus by Heald, S. C., Davies, D. W., Ward, D. E., Garratt, C. J., Rowland, E.

“…BACKGROUND--Reentrant tachycardias associated with Mahaim pathways are rare but potentially troublesome. Various electrophysiological substrates have been…”
Get full text

Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation by Stafford, P. J., Cooper, J., de Bono, D. P., Vincent, R., Garratt, C. J.

“…OBJECTIVE--To investigate the effects of low dose sotalol on the signal averaged surface P wave in patients with paroxysmal atrial fibrillation. DESIGN--A…”
Get full text

RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?' by Stott, D J, Dewar, R I, Garratt, C J, Griffith, K E, Harding, N J, James, M A, Lane, D A, Petty, D R, Smith, P A, Somerville, M H, Trueland, J

Get full text

Dynamics of QT dispersion during myocardial infarction and ischaemia by Glancy, James M., Garratt, Clifford J., de Bono, David P.

“…We studied the dynamics of QT dispersion over the first few days of myocardial infarction and during coronary angioplasty. Ten patients with anterior…”
Get full text

Use of lead adjustment formulas for QT dispersion after myocardial infarction by Glancy, J. M., Garratt, C. J., Woods, K. L., de Bono, D. P.

“…OBJECTIVE--To determine whether lead adjustment formulas for correcting QT dispersion measurements are appropriate in patients after myocardial infarction…”
Get full text

In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism by Crespi, F, Garratt, J C, Sleight, A J, Marsden, C A

“…The relationship between 5-hydroxytryptamine release, metabolism and unit activity has been investigated in the anaesthetized rat. 5-Hydroxytryptamine release…”
Get more information

Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data by Pathmanathan, R K, Lau, E W, Cooper, J, Newton, L, Skehan, J D, Garratt, C J, Griffith, M J

“…Background Survival was prolonged in selected patients with sustained ventricular arrhythmias who received implantable cardioverter defibrillators (ICDs) in…”
Get full text

Management of hypertension in general practice: agreements with and variations from the British Hypertension Society guidelines by Dickerson, J E, Garratt, C J, Brown, M J

“…A random sample of 200 East Anglian general practitioners was surveyed to establish current trends in the management of hypertension, including measurement of…”
Get more information